BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23232601)

  • 1. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
    Waubant E; Mowry EM; Krupp L; Chitnis T; Yeh EA; Kuntz N; Ness J; Belman A; Milazzo M; Gorman M; Weinstock-Guttman B; Rodriguez M; James JA
    Mult Scler; 2013 Jun; 19(7):891-5. PubMed ID: 23232601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common viruses associated with lower pediatric multiple sclerosis risk.
    Waubant E; Mowry EM; Krupp L; Chitnis T; Yeh EA; Kuntz N; Ness J; Chabas D; Strober J; McDonald J; Belman A; Milazzo M; Gorman M; Weinstock-Guttman B; Rodriguez M; Oksenberg JR; James JA;
    Neurology; 2011 Jun; 76(23):1989-95. PubMed ID: 21646624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
    De Jager PL; Simon KC; Munger KL; Rioux JD; Hafler DA; Ascherio A
    Neurology; 2008 Mar; 70(13 Pt 2):1113-8. PubMed ID: 18272866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
    Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
    Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.
    Al-Temaimi R; Alroughani R; Jacob S; Al-Mulla F
    J Neuroimmunol; 2015 Aug; 285():57-61. PubMed ID: 26198919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis.
    Ziaei A; Solomon O; Casper TC; Waltz M; Weinstock-Guttman B; Aaen G; Wheeler Y; Graves J; Benson L; Gorman M; Rensel M; Mar S; Lotze T; Greenberg B; Chitnis T; Waldman AT; Krupp L; James JA; Hart J; Barcellos LF; Waubant E
    Mult Scler; 2024 Mar; 30(3):308-315. PubMed ID: 38332747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study.
    Langer-Gould A; Wu J; Lucas R; Smith J; Gonzales E; Amezcua L; Haraszti S; Chen LH; Quach H; James JA; Barcellos LF; Xiang AH
    Neurology; 2017 Sep; 89(13):1330-1337. PubMed ID: 28855411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis and Epstein-Barr virus.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study.
    Domínguez-Mozo MI; López-Lozano L; Pérez-Pérez S; García-Martínez Á; Torrejón MJ; Arroyo R; Álvarez-Lafuente R
    Front Immunol; 2022; 13():991662. PubMed ID: 36189297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Epstein-Barr virus infection with multiple sclerosis in India.
    Pandit L; Malli C; D'Cunha A; Shetty R; Singhal B
    J Neurol Sci; 2013 Feb; 325(1-2):86-9. PubMed ID: 23312038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.
    Csuka D; Simon D; Hóbor R; Uray K; Prohászka Z; Bánlaki Z; Jani PK; Szilágyi Á; Hudecz F; Rajczy K; Beke G; Boros Major A; Tordai A; Illés Z; Berki T; Czirják L; Füst G
    Clin Exp Immunol; 2013 Mar; 171(3):255-62. PubMed ID: 23379431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA alleles modulate EBV viral load in multiple sclerosis.
    Agostini S; Mancuso R; Guerini FR; D'Alfonso S; Agliardi C; Hernis A; Zanzottera M; Barizzone N; Leone MA; Caputo D; Rovaris M; Clerici M
    J Transl Med; 2018 Mar; 16(1):80. PubMed ID: 29587799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study.
    Sundström P; Nyström L; Jidell E; Hallmans G
    Mult Scler; 2008 Sep; 14(8):1120-2. PubMed ID: 18573815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of early viral infections in development of multiple sclerosis.
    Djelilovic-Vranic J; Alajbegovic A
    Med Arch; 2012; 66(3 Suppl 1):37-40. PubMed ID: 22937690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis.
    Lindsey JW; Hatfield LM; Vu T
    Eur J Neurol; 2010 Oct; 17(10):1263-9. PubMed ID: 20402753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
    Rubicz R; Yolken R; Drigalenko E; Carless MA; Dyer TD; Bauman L; Melton PE; Kent JW; Harley JB; Curran JE; Johnson MP; Cole SA; Almasy L; Moses EK; Dhurandhar NV; Kraig E; Blangero J; Leach CT; Göring HH
    PLoS Genet; 2013; 9(1):e1003147. PubMed ID: 23326239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.